CN Patent
CN1190893A — 用作传送活性剂的化合物和组合物
Assigned to Emisphere Technologies Inc · Expires 1998-08-19 · 28y expired
What this patent protects
本发明涉及将修饰氨基酸化合物用于活性剂的传送。活性剂可以是肽如rhGH。本发明还涉及给药方法,如口服,皮下,舌下和鼻内给药,并涉及修饰氨基酸的制备方法。
USPTO Abstract
本发明涉及将修饰氨基酸化合物用于活性剂的传送。活性剂可以是肽如rhGH。本发明还涉及给药方法,如口服,皮下,舌下和鼻内给药,并涉及修饰氨基酸的制备方法。
Drugs covered by this patent
- Ozempic (semaglutide) · Novo Nordisk
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.